| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |